Canopy Growth Q4 revenue down 11% YoY to $65M; adjusted EBITDA loss improves 39% to $9.2M

Canopy Growth Corp

2025-FY EPS reported -$5.56 vs consensus -$0.05 ▼ miss (-12013.3%)

Net revenue $65M in Q4 FY2025, down 11% YoY; net loss from continuing ops $221.5M.
Canada medical cannabis revenue up 13% YoY; adult-use down 3%; international down 35%.
Total debt reduced 49% in FY2025 to $304M; cost savings target at least $20M annualized over 12-18 months.
Storz & Bickel revenue down 23% to $17.1M in Q4; FY2025 revenue up 4% to $73.4M.
Acreage in default; lenders forbear until June 1, 2025 while discussing potential debt extension.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.